| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −53.8× | −1.8× | |
| Price / Book | 8.3× | 2.1× | |
| Price / Sales | 3.5× | 4.0× | |
| Price / Free cash flow | −302.0× | −1.6× | |
| EV / EBITDA | −75.7× | −1.1× | |
| Earnings yield | −1.9% | −14.1% | |
| Free cash flow yield | −0.3% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.41 | −1.78% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.52 | −1.53% | $634.37B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.48 | −0.60% | $500.94B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $422.22 | −0.65% | $378.98B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.50 | −1.86% | $356.51B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.46 | −0.52% | $280.13B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.87 | −0.99% | $265B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $674.19 | −0.35% | $249.28B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.25 | −1.12% | $239.09B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.12 | −0.04% | $194.82B | 22.9× | 37.5% | +26.7% |
